Traders are getting smarter about the vaccine race

Commentary / World Sep 11, 2020

Traders are getting smarter about the vaccine race

by Max Nisen

Investors watching the COVID-19 vaccine development process could be forgiven for thinking it's not so hard. The effort has moved extraordinarily quickly so far, and with few hiccups. That isn’t how things usually go, especially for new diseases. The world got a reminder Tuesday as ...

Editorials May 8, 2013

Lessons from the Iressa case

The Supreme Court upholds rulings that the Japanese unit of British drug maker AstraZeneca PLC is not liable for fatal side effects of the lung cancer drug Iressa.